Abstract:

This article includes the assessment of fibrous medical devices as well as borderline products from the point of view of expenditures necessary for the realisation of research and implementation in industrial and clinical practices, the range of practice implementation benefits as well as potential barriers restricting studies and implementation. The scale of investment necessary for the realisation of research and implementation in industrial practices in relation to the benefits of implementing them in practice as well as the limitations that restrict the research and implementation of selected fibrous technologies for medical devices are discussed in detail.